Validation of a nomogram model for Plastic Bronchitis in Pediatric
Mycoplasma pneumoniae Pneumonia
Abstract
Background: Plastic bronchitis (PB) is a severe condition
requiring early identification and treatment. The aim of this study is
to analyze the clinical characteristics and risk factors for PB in
pediatric Mycoplasma pneumoniae pneumonia (MPP), and to develop
and validate a nomogram model for prediction. Methods: A
retrospective analysis involved clinical data from 421 children
diagnosed with MPP who underwent fiberoptic bronchoscopy in Wuxi
Children’s Hospital from January 2022 to December 2023. Basing on
bronchoscopic findings, 90 children were assigned into PB and 331 to
non-PB. For external validation, the study considered 354 children
diagnosed with MPP between January and May 2024 at the same hospital.
The study identified independent risk factors for PB using LASSO and
multivariate logistic regression and constructed and validated a visual
predictive model. Bootstrap was used for internal validation. ROC
curves, calibration curves and DCA curves assessed the model. An online
dynamic nomogram tool was also launched for clinician use.
Results: Children in the PB group experienced longer hospital
stays, higher fever peaks, and required more oxygen therapy compared to
the non-PB group. They also showed symptoms of shortness of breath,
depression, reduced lung sounds, and elevated levels of ANC, NLR, CRP,
ALT, AST, LDH, CK, INR, D-D, as well as increased incidences of
pneumonia consolidation, pleural effusion, and atelectasis (all
P<0.05). Factors such as oxygen therapy, fever duration,
atelectasis, NLR, CK, and D-D significantly influenced PB development
(all p<0.05). The ROC curve showed that the nomogram model had
an AUC of 0.88 (95% CI: 0.84-0.93), with a sensitivity of 94.74% and a
specificity of 74.63%. In the validation cohort, the AUC was 0.9 (95%
CI: 0.84-0.98), with a sensitivity of 84.44% and specificity of
80.97%. Calibration curves showed strong consistency between predicted
and actual PB occurrence rates. DCA confirmed the significant net
benefit of the predictive model. Conclusion: This study
developed and validated a predictive model for PB in pediatric MPP,
using key factors such as oxygen therapy, fever duration, atelectasis,
NLR, CK, and D-D. The model demonstrates excellent predictive accuracy
and offers a useful tool for clinicians, enhancing early PB
identification.